Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict Desloratadine Pharmacokinetics in Children

被引：0
|
作者：
Zhou, W. [1 ]
Johnson, T. [2 ]
Bui, K. [1 ]
Cheung, S. Y. A. [3 ]
Li, J. [1 ]
Xu, H. [1 ]
Al-Huniti, N. [1 ]
Zhou, D. [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
[2] Simcyp, Sheffield, S Yorkshire, England
[3] AstraZeneca, Cambridge, England
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-090
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [41] Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination
    Lei Sun
    Lisa von Moltke
    Karen Rowland Yeo
    Clinical Pharmacokinetics, 2021, 60 : 637 - 647
  • [42] Physiologically based Pharmacokinetic/Pharmacodynamic Modeling (PBPK/PD) of Famotidine in Pregnancy
    Liu, Xiaomei I.
    Green, Dionna J.
    van den Anker, John
    Ahmadzia, Homa K.
    Calderon, Joaquin
    Burckart, Gilbert J.
    Dallmann, Andre
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [43] Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
    Shaik, Abdul Naveed
    Khan, Ansar Ali
    ADMET AND DMPK, 2019, 7 (01): : 1 - 3
  • [44] Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
    Peters, Sheila Annie
    Ungell, Anna-Lena
    Dolgos, Hugues
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 509 - 518
  • [45] Physiologically based pharmacokinetic (PBPK) modeling of perfluorohexane sulfonate (PFHxS) in humans
    Sweeney, Lisa M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2022, 129
  • [46] Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric Patients
    Guo, Guimu
    You, Xiang
    Wu, Wanhong
    Chen, Jiarui
    Ke, Meng
    Lin, Rongfang
    Huang, Pinfang
    Lin, Cuihong
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (03) : 724 - 734
  • [47] Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
    Fairman, Kiara
    Li, Miao
    Ning, Baitang
    Lumen, Annie
    BIOCHEMICAL PHARMACOLOGY, 2021, 189
  • [48] Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
    Cuello, W. S.
    Janes, T. A. T.
    Jessee, J. M.
    Venecek, M. A.
    Sawyer, M. E.
    Eklund, C. R.
    Evans, M. V.
    JOURNAL OF TOXICOLOGY, 2012, 2012
  • [49] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [50] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).
    Duan, P.
    Zhao, P.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S16 - S17
12345